Stockscreener 앱 받기
332.92
2.98%
9.63
시간 외 거래:
337.00
4.08
+1.23%
전일 마감가:
$323.29
열려 있는:
$323.99
하루 거래량:
419.25K
Relative Volume:
0.59
시가총액:
$9.23B
수익:
$1.77M
순이익/손실:
$-123.74M
주가수익비율:
-36.31
EPS:
-9.17
순현금흐름:
$-95.21M
1주 성능:
+8.93%
1개월 성능:
+20.74%
6개월 성능:
+587.00%
1년 성능:
+289.84%
1일 변동 폭
$317.82
$335.75
1주일 범위
$302.00
$335.75
52주 변동 폭
$26.70
$335.75
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
명칭
Praxis Precision Medicines Inc
전화
617-300-8460
주소
99 HIGH STREET, 30TH FLOOR, BOSTON
Compare PRAX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
332.92 | 8.97B | 1.77M | -123.74M | -95.21M | -9.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-02 | 개시 | Wells Fargo | Equal Weight |
| 2025-12-15 | 재확인 | Oppenheimer | Outperform |
| 2025-11-19 | 개시 | BTIG Research | Buy |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-07 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-03 | 재확인 | H.C. Wainwright | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-08-05 | 개시 | Oppenheimer | Outperform |
| 2024-06-24 | 개시 | Needham | Buy |
| 2024-06-18 | 개시 | Guggenheim | Buy |
| 2024-05-01 | 개시 | Robert W. Baird | Outperform |
| 2023-09-19 | 개시 | Truist | Buy |
| 2022-06-06 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-12-16 | 개시 | H.C. Wainwright | Buy |
| 2021-08-26 | 개시 | BofA Securities | Buy |
| 2021-04-26 | 개시 | William Blair | Outperform |
| 2020-11-11 | 개시 | Wedbush | Outperform |
| 2020-11-10 | 개시 | Cowen | Outperform |
| 2020-11-10 | 개시 | Evercore ISI | Outperform |
| 2020-11-10 | 개시 | Piper Sandler | Overweight |
모두보기
Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스
PRAX: Two NDAs set for mid-February aim to address major CNS markets with strong launch plans - TradingView
Praxis Precision Medicines stock hits 52-week high at 327.0 USD - Investing.com Nigeria
Arizona State Retirement System Purchases Shares of 5,417 Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Will Praxis Precision Medicines Inc. stock attract more institutional investors2025 Price Targets & Real-Time Stock Price Movement Reports - mfd.ru
Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) | PRAX Stock News - GuruFocus
Guggenheim raises Praxis Precision Medicines stock price target on essential tremor opportunity - Investing.com India
Praxis Precision Medicines (NASDAQ:PRAX) Hits New 1-Year HighHere's Why - MarketBeat
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences - Investing News Network
Praxis Precision Medicines to Report Fourth Quarter and - GlobeNewswire
Praxis Precision Medicines stock hits 52-week high at 327.0 USD By Investing.com - Investing.com South Africa
A Look At Praxis Precision Medicines (PRAX) Valuation As Analysts Reaffirm Bullish CNS Pipeline Views - Yahoo Finance
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Avoiding Lag: Real-Time Signals in (PRAX) Movement - Stock Traders Daily
Certain Stock Options of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 6-FEB-2026. - marketscreener.com
Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 6-FEB-2026. - marketscreener.com
Is Praxis Precision Medicines (PRAX) Now Pricing In Recent Pipeline Progress And Volatile Share Gains - Sahm
Praxis Precision Medicines (PRAX) Price Target Increased by 26.75% to 597.99 - Nasdaq
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Praxis Precision Medicines, Inc. announces inducement grants under Nasdaq Listing Rule - marketscreener.com
Needham Raises Price Target for Praxis Precision Medicine (PRAX) - GuruFocus
Needham & Company LLC Boosts Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $510.00 - MarketBeat
Why Praxis Precision Medicines (PRAX) Is Up 5.1% After Dual NDA Plans And Data Platform Expansion - Sahm
Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Praxis Precision Medicines (PRAX) - The Globe and Mail
Wells Fargo Initiates Coverage of Praxis Precision Medicines (PRAX) with Equal-Weight Recommendation - Nasdaq
SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders - 01net
Wells Fargo Initiates Coverage on PRAX with Equal-Weight Rating - GuruFocus
Wells Fargo Initiates Coverage on Praxis Precision Medicines With Equal Weight Rating, $282 Price Target - marketscreener.com
Praxis Precision Medicines (NASDAQ:PRAX) Now Covered by Analysts at Wells Fargo & Company - MarketBeat
A Look At Praxis Precision Medicines (PRAX) Valuation After Breakthrough NDA Plans And Rising Investor Interest - Sahm
Aug Chart Watch: Is Praxis Precision Medicines Inc stock a smart retirement pickAnalyst Upgrade & Safe Capital Growth Tips - baoquankhu1.vn
3,846 Shares in Praxis Precision Medicines, Inc. $PRAX Acquired by Coastal Bridge Advisors LLC - MarketBeat
Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring a 63% Upside in the Biotech Sector - DirectorsTalk Interviews
PRAX: HC Wainwright & Co. Raises Price Target and Maintains Buy Rating | PRAX Stock News - GuruFocus
H.C. Wainwright raises Praxis Precision Medicines stock price target to $1,245 - Investing.com Nigeria
Y Intercept Hong Kong Ltd Makes New $1.71 Million Investment in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines plans two NDA submissions by mid-February - Investing.com Nigeria
Phoenix Financial Ltd. Makes New Investment in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Piper Sandler raises Praxis Precision Medicines stock price target to $1,200 - Investing.com Canada
Is Praxis Precision Medicines Inc part of any major indexTrade Analysis Report & Daily Market Momentum Tracking - baoquankhu1.vn
Piper Sandler Raises PRAX Price Target to $1,200, Maintains Overweight Rating | PRAX Stock News - GuruFocus
Discipline and Rules-Based Execution in PRAX Response - Stock Traders Daily
A Look At Praxis Precision Medicines (PRAX) Valuation As Late Stage Epilepsy Plans Move Toward FDA Filings - Sahm
Should Praxis Precision Medicines’ (PRAX) New Clinical Strategy Chief Reshape Its Long-Term Epilepsy Investment Story? - Sahm
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $450 - 富途牛牛
Piper Sandler reiterates Overweight rating on Praxis Precision Medicines stock - Investing.com
SG Americas Securities LLC Invests $715,000 in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
PRAX Stock Price, Forecast & Analysis | PRAXIS PRECISION MEDICINES I (NASDAQ:PRAX) - Chartmill
Praxis speeds up R&D plans for seizure therapy after FDA feedback - MSN
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Nisa Investment Advisors LLC Has $378,000 Stake in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines stock hits 52-week high at $318.24 By Investing.com - Investing.com Nigeria
Praxis Precision Medicines Inc (PRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Praxis Precision Medicines Inc 주식 (PRAX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nemiroff Alex | General Counsel and Secretary |
Nov 20 '25 |
Sale |
193.09 |
25,130 |
4,852,256 |
20,832 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 20 '25 |
Option Exercise |
61.12 |
13,600 |
831,257 |
24,042 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 20 '25 |
Sale |
192.08 |
13,600 |
2,612,244 |
10,442 |
1.24%
0.19%
자본화:
|
볼륨(24시간):